Lantern Pharma Inc. 8-K

What Happened
Lantern Pharma Inc. (LTRN) filed a Current Report on Form 8-K on May 15, 2026 (Item 2.02) announcing that it will issue a press release with its financial results for the first quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K and the cover page interactive data file is provided as Exhibit 104 (Inline XBRL).

Key Details

• Filing date: May 15, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: Quarter ended March 31, 2026 (Q1 2026).
• Press release: Furnished as Exhibit 99.1 to the Form 8-K.
• Data format: Cover Page Interactive Data File included as Exhibit 104 (Inline XBRL).

Why It Matters
This filing signals that Lantern Pharma's quarterly earnings, revenue and other key financial metrics for Q1 2026 are now available via the company press release. Retail investors should review the press release and any accompanying financial statements or disclosures to see reported revenue, net income/loss, cash position and any management commentary on business progress or guidance, as these figures can affect valuation and near-term trading decisions.